Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Xeljanz XR (tofacitinib citrate) Modified Release Tablets For the Treatment of Rheumatoid Arthritis

Drug (Brand / Generic)

Xeljanz XR (tofacitinib citrate)

Company

Pfizer

Therapy Class

JAK inhibitor

Current Indication

Rheumatoid Arthritis

Market Sector

Rheumatology

Current Status

Approved in the US
Expand

Go Top